Contact Jennifer E. Girotto, PharmD, BCPPS, BCIDP

Jennifer E. Girotto, PharmD, BCPPS, BCIDP

Practice Name Connecticut Children's Specialty Group
Education

Education:

PharmD, University of Connecticut School of Pharmacy

Residency:

Pediatric Pharmacy, Boston Children’s Hospital

Board Certifications
  • Pediatric Pharmacotherapy Specialist
  • Infectious Disease Pharmacist
  • Faculty Appointment

    Associate Clinical Professor, Pharmacy Practice, University of Connecticut, School of Pharmacy and Associate Clinical Professor, Pediatrics, University of Connecticut School of Medicine

    Clinical Expertise

    Dr. Girotto  is the Co-Director of the Antimicrobial Stewardship Program

    Selected Publications
    • Dulek DE, Fuhlbrigge RC, Tribble AC, Connelly JA, Loi MM, El Chebib H, Chandrakasan S, Otto WR, Diorio C, Keim G, Walkovich K, Jaggi P, Girotto JE, Yarbrough A, Behrens E, Cron RQ, Bassiri H.  Multidisciplinary guidance regarding the use of immunomodulary therapies for acute COVID-19 in pediatric patients.  J Pediatr Infect Dis Soc  Aug 18:piaa098. doi: 10.1093/jpids/piaa098. Online ahead of print

    • Nielsen LE, Forrester JB, Girotto JE, Dassner AM, Humphries R.  One-size fits all?  Application of susceptible-dose dependent breakpoints to pediatric patients and laboratory reporting.  J Clin Microb 2019 58(1):e01446-19.

    • Stimes GT, Girotto JE.  Applying pharmacodynamics and antimicrobial stewardship to pediatric preseptal and orbital cellulitis.  Paediatr Drugs 2019; 21(6):427-438.

    • Tong K, Girotto JE. Vaccinating against pneumococcal disease:  Covering more than just pneumonia.  Connecticut Medicine 2019; August 83:357-361.

    • DeRonde K, Girotto JE, Nicolau DP.  Management of pediatric acute hematogenous osteomyelitis, Part II: A focus on methicillin-resistant Staphylococcus aureus, current and emerging therapies.  Pharmacotherapy 2018 Oct;38:1021-1037.

    • DeRonde K, Girotto JE, Nicolau DP.  Management of pediatric acute hematogenous osteomyelitis, Part 1: Antimicrobial stewardship approach and review of therapies for methicillin-sensitive Staphylococcus aureus, Streptococcus pyogenes and Kingella kingae.  Pharmacotherapy.  2018 Sep;38;947-966. 

    • Nichols K, Stoffella S, Meyers R, Girotto J; Advocacy Committee for the Pediatric Pharmacy Group.  Pediatric Antimicrobial Stewardship Programs. Journal Pediatr Pharm Ther.   2017; 22 (1):77-80. 

    • Nichols K, Girotto J, Mitchell-Van Steele AM, Stoffella S; Advocacy Committee for the Pediatric Pharmacy Group.  Duty to Advocate: Human Papillomavirus Vaccination.  Journal Pediatr Pharm Ther.   2017; 22 (1):74-76. 

    • Dassner A, Sutherland C, Girotto J, Nicolau D.  In Vitro Antimicrobial activity of Ceftolozane/Tazobactam Alone or with an Aminoglycoside Against Multi-Drug Resistant Pseudomonas aeruginosa Isolates from Pediatric Cystic Fibrosis Patients.  Infect Dis Ther. 2017 Mar; 6(1):129-136. Doi: 10.1007/s40121-016-0141-y. Epub 2016 Dec 9.

    • Courter JD, Nichols K, Kazazian C, Girotto JE.  Optimal levofloxacin dosing for pediatric community-acquired pneumonia.  J Pediatric Infect Dis Soc. 2017 Jun 1;6(2):118-122.

    • Welsh C, Miah R, Girotto J.  Survey evaluating the practice of children’s hospitals having pharmacist collaborative drug therapy management protocols.  Journal of Pediatric Pharmacology and Therapeutics 2016; Nov-Dec. 21 (6); 494-501.

    Back to Top
    Searching Animation
    Searching